Cargando…

Patient-Derived Cellular Models for Polytarget Precision Medicine in Pantothenate Kinase-Associated Neurodegeneration

The term neurodegeneration with brain iron accumulation (NBIA) brings together a broad set of progressive and disabling neurological genetic disorders in which iron is deposited preferentially in certain areas of the brain. Among NBIA disorders, the most frequent subtype is pantothenate kinase-assoc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Álvarez-Córdoba, Mónica, Talaverón-Rey, Marta, Povea-Cabello, Suleva, Cilleros-Holgado, Paula, Gómez-Fernández, David, Piñero-Pérez, Rocío, Reche-López, Diana, Munuera-Cabeza, Manuel, Suárez-Carrillo, Alejandra, Romero-González, Ana, Romero-Domínguez, Jose Manuel, López-Cabrera, Alejandra, Armengol, José Ángel, Sánchez-Alcázar, José Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10609847/ https://www.ncbi.nlm.nih.gov/pubmed/37895830 http://dx.doi.org/10.3390/ph16101359

Ejemplares similares

Therapeutic approach with commercial supplements for pantothenate kinase-associated neurodegeneration with residual PANK2 expression levels
por: Álvarez-Córdoba, Mónica, et al.
Publicado: (2022)

Alpha-lipoic acid supplementation corrects pathological alterations in cellular models of pantothenate kinase-associated neurodegeneration with residual PANK2 expression levels
por: Talaverón-Rey, Marta, et al.
Publicado: (2023)

Pantothenate and L-Carnitine Supplementation Improves Pathological Alterations in Cellular Models of KAT6A Syndrome
por: Munuera-Cabeza, Manuel, et al.
Publicado: (2022)

Vicious cycle of lipid peroxidation and iron accumulation in neurodegeneration
por: Villalón-García, Irene, et al.
Publicado: (2022)

Down regulation of the expression of mitochondrial phosphopantetheinyl-proteins in pantothenate kinase-associated neurodegeneration: pathophysiological consequences and therapeutic perspectives
por: Álvarez-Córdoba, Mónica, et al.
Publicado: (2021)

Neurodegeneration, Mitochondria, and Antibiotics
por: Suárez-Rivero, Juan M., et al.
Publicado: (2023)

mtUPR Modulation as a Therapeutic Target for Primary and Secondary Mitochondrial Diseases
por: Cilleros-Holgado, Paula, et al.
Publicado: (2023)

Precision medicine in pantothenate kinase-associated neurodegeneration
por: Álvarez-Córdoba, Mónica, et al.
Publicado: (2019)

UPR(mt) activation improves pathological alterations in cellular models of mitochondrial diseases
por: Suárez-Rivero, Juan M., et al.
Publicado: (2022)

Activation of the Mitochondrial Unfolded Protein Response: A New Therapeutic Target?
por: Suárez-Rivero, Juan M., et al.
Publicado: (2022)

Precision Medicine in Rare Diseases
por: Villalón-García, Irene, et al.
Publicado: (2020)

Advances in mt-tRNA Mutation-Caused Mitochondrial Disease Modeling: Patients’ Brain in a Dish
por: Povea-Cabello, Suleva, et al.
Publicado: (2021)

Coenzyme Q(10): Novel Formulations and Medical Trends
por: Pastor-Maldonado, Carmen J., et al.
Publicado: (2020)

Coenzyme Q(10) Analogues: Benefits and Challenges for Therapeutics
por: Suárez-Rivero, Juan M., et al.
Publicado: (2021)

From Mitochondria to Atherosclerosis: The Inflammation Path
por: Suárez-Rivero, Juan M., et al.
Publicado: (2021)

Mitochondria and Antibiotics: For Good or for Evil?
por: Suárez-Rivero, Juan M., et al.
Publicado: (2021)

Pterostilbene in Combination With Mitochondrial Cofactors Improve Mitochondrial Function in Cellular Models of Mitochondrial Diseases
por: Suárez-Rivero, Juan M., et al.
Publicado: (2022)

Atherosclerosis and Coenzyme Q(10)
por: Suárez-Rivero, Juan M., et al.
Publicado: (2019)

Pantothenate kinase-associated neurodegeneration
por: Hundallah, Khalid, et al.
Publicado: (2017)

Pantothenate kinase-associated neurodegeneration is not a synucleinopathy
por: Li, A, et al.
Publicado: (2013)

Proposed Therapies for Pantothenate-Kinase-Associated Neurodegeneration
por: Jackowski, Suzanne
Publicado: (2019)

Redesigning therapies for pantothenate kinase–associated neurodegeneration
por: Munshi, Muhammad I., et al.
Publicado: (2022)

Late Onset Atypical Pantothenate-Kinase-Associated Neurodegeneration
por: Diaz, Natalie
Publicado: (2013)

Deep Brain Stimulation for Pantothenate Kinase-Associated Neurodegeneration
por: Garcia-Ruiz, Pedro J., et al.
Publicado: (2015)

A therapeutic approach to pantothenate kinase associated neurodegeneration
por: Sharma, Lalit Kumar, et al.
Publicado: (2018)

Eye of the Tiger Sign in Pantothenate Kinase-Associated Neurodegeneration
por: Choayb, S., et al.
Publicado: (2021)

Genetic mutation spectrum of pantothenate kinase-associated neurodegeneration expanded by breakpoint sequencing in pantothenate kinase 2 gene
por: Yang, Dahae, et al.
Publicado: (2022)

Magnetic resonance imaging in pantothenate kinase-2-associated neurodegeneration
por: Singh, Paramdeep, et al.
Publicado: (2012)

Clinical Heterogeneity of Atypical Pantothenate Kinase-Associated Neurodegeneration in Koreans
por: Lee, Jae-Hyeok, et al.
Publicado: (2016)

Pantothenate kinase-associated neurodegeneration: Clinical aspects, diagnosis and treatments
por: Razmeh, Saeed, et al.
Publicado: (2018)

Diagnostic and clinical experience of patients with pantothenate kinase-associated neurodegeneration
por: Marshall, Randall D., et al.
Publicado: (2019)

Harmful Iron-Calcium Relationship in Pantothenate kinase Associated Neurodegeneration
por: Santambrogio, Paolo, et al.
Publicado: (2020)

Fosmetpantotenate Randomized Controlled Trial in Pantothenate Kinase–Associated Neurodegeneration
por: Klopstock, Thomas, et al.
Publicado: (2020)

Novel Compound Heterozygous Mutations in the Pantothenate Kinase 2 Gene in a Korean Patient with Atypical Pantothenate Kinase Associated Neurodegeneration
por: Kim, Sung-Hyouk, et al.
Publicado: (2009)

Dynamic Reorganization of the Cytoskeleton during Apoptosis: The Two Coffins Hypothesis
por: Povea-Cabello, Suleva, et al.
Publicado: (2017)

Case report: MR spectroscopy in pantothenate kinase-2 associated neurodegeneration
por: Parashari, Umesh C, et al.
Publicado: (2010)

Pantothenate kinase 2 deficiency: A neurodegeneration with brain iron accumulation
por: Yousaf, Muhammad, et al.
Publicado: (2015)

A pilot trial of deferiprone in pantothenate kinase-associated neurodegeneration patients
por: Rohani, Mohammad, et al.
Publicado: (2018)

Natural history and genotype‐phenotype correlation of pantothenate kinase‐associated neurodegeneration
por: Chang, Xuting, et al.
Publicado: (2020)

Atypical pantothenate kinase-associated neurodegeneration with variable phenotypes in an Egyptian family
por: Shalash, Ali S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s26e2ek73lt9ggmjoafhu1pbem